From July 1, 2022 to December 31, 2022, the company has repurchased 676,994 shares, representing 0.21% for CNY 43.31 million. With this, the company has completed the repurchase of 1,436,614 shares, representing 0.45% for CNY 98.02 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.22 CNY | +6.34% | +5.26% | -3.21% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.21% | 1.62B | |
+7.93% | 219B | |
+7.53% | 183B | |
+15.20% | 136B | |
+27.02% | 107B | |
-1.14% | 63.07B | |
+7.23% | 52.55B | |
+12.58% | 51.28B | |
+1.61% | 41.21B | |
+5.32% | 36.43B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.